2seventy bio
Stock Forecast, Prediction & Price Target

2seventy bio Financial Estimates

2seventy bio Revenue Estimates

2seventy bio EBITDA Estimates

2seventy bio Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$54.52M
 
N/A
$91.49M
 
67.81%
$100.38M
 
9.71%
Avg: $94.55M
Low: $62.17M
High: $124.67M
avg. -5.80%
Avg: $85.26M
Low: $56.04M
High: $136.07M
avg. -9.82%
Avg: $117.99M
Low: $77.55M
High: $188.30M
avg. 38.38%
Avg: $137.93M
Low: $90.66M
High: $220.12M
avg. 16.89%
Net Income
 
% change YoY
$-276.21M
 
N/A
$-254.14M
 
7.99%
$-217.57M
 
14.39%
Avg: $-17.91M
Low: $-75.39M
High: $68.49M
avg. 91.76%
Avg: $-6.24M
Low: $-51.24M
High: $40.89M
avg. 65.15%
Avg: $32.02M
Low: $17.76M
High: $56.84M
avg. 613.12%
Avg: $50.01M
Low: $27.73M
High: $88.76M
avg. 56.15%
EBITDA
 
% change YoY
$-313.07M
 
N/A
$-251.14M
 
19.78%
$-206.41M
 
17.80%
Avg: $-84.28M
Low: $-111.13M
High: $-55.42M
avg. 59.16%
Avg: $-76.00M
Low: $-121.30M
High: $-49.95M
avg. 9.82%
Avg: $-105.17M
Low: $-167.85M
High: $-69.13M
avg. -38.38%
Avg: $-122.95M
Low: $-196.22M
High: $-80.81M
avg. -16.89%
EPS
 
% change YoY
-$11.71
 
N/A
-$7.13
 
39.11%
-$4.42
 
38.00%
Avg: -$0.51
Low: -$1.53
High: $1.39
avg. 88.46%
Avg: -$0.19
Low: -$1.04
High: $0.83
avg. 62.74%
Avg: $0.65
Low: $0.36
High: $1.15
avg. 442.10%
Avg: $1.02
Low: $0.56
High: $1.8
avg. 56.15%
Operating Expenses
 
% change YoY
$355.44M
 
N/A
$328.18M
 
-7.66%
$321.07M
 
-2.16%
Avg: $103.71M
Low: $68.20M
High: $136.75M
avg. -67.69%
Avg: $93.52M
Low: $61.47M
High: $149.26M
avg. -9.82%
Avg: $129.42M
Low: $85.07M
High: $206.55M
avg. 38.38%
Avg: $151.29M
Low: $99.44M
High: $241.45M
avg. 16.89%

FAQ

What is 2seventy bio stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 206.54% in 2025-2028.

We have gathered data from 4 analysts. Their low estimate is -75.39M, average is -17.91M and high is 68.49M.

What is 2seventy bio stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 9.91% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is $62.17M, average is $94.55M and high is $124.67M.

What is 2seventy bio stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 162.36% in 2025-2028.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.53, average is -$0.51 and high is $1.39.

What is the best performing analyst?

In the last twelve months analysts have been covering 2seventy bio stock. The most successful analyst is Salveen Richter.